TY - GEN
T1 - The antioxidant effects of melatonin in surgical brain injury in rats
AU - Lee, Steve
AU - Jadhav, Vikram
AU - Ayer, Robert
AU - Rojas, Hugo
AU - Hyong, Amy
AU - Lekic, Tim
AU - Stier, Gary
AU - Martin, Robert
AU - Zhang, John H.
N1 - Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 102) Background Surgical brain injury (SBI) to normal brain tissue can occur as inevitable sequelae of neurosurgical operations. SBI can contribute to post-operative complications such as brain edema following blood-brain barrier (BBB) disruption leading to neurological deficits.
PY - 2009/1/9
Y1 - 2009/1/9
N2 - Background Surgical brain injury (SBI) to normal brain tissue can occur as inevitable sequelae of neurosurgical operations. SBI can contribute to post-operative complications such as brain edema following blood-brain barrier (BBB) disruption leading to neurological deficits. Melatonin is a commonly used drug with known antioxidant properties and neuroprotective effects in experimental animal studies (Chen et al., J Pineal Res 41:175-182, 2006; Chen et al., J Pineal Res 40(3):242-250, 2006; Cheung, J Pineal Res 34:153-160, 2003; Lee et al., J Pineal Res 42(3):297-309, 2007; Reiter et al., Exp Biol Med (Maywood) 230(2):104-117, 2005) Methods We tested different concentrations of melatonin (5 mg/kg, 15 mg/kg and 150 mg/kg) administered 1 hour before surgery for neuroprotection against SBI using a rodent model. Post-operative assessment included brain water content (brain edema), lipid peroxidation assays (oxidative stress), and neurological assessment. Findings The results showed a trend in decreasing brain edema with lower doses of melatonin (5 mg/kg and 15 mg/ kg), however, high concentration of melatonin (150 mg/kg) significantly increased brain edema compared to all other groups. This deleterious effect of high-dose melatonin was also observed in lipid-peroxidation assay wherein lower-dose melatonin (15 mg/kg) attenuated oxidative stress, but high-dose melatonin (150 mg/kg) increased oxidative stress as compared to vehicle-treated group. Furthermore, high-dose melatonin also worsened neurological outcomes compared to other groups whereas; the low-dose melatonin group (15 mg/kg) showed some improved neurological parameters. Conclusions The study suggests that low-dose melatonin may provide neuroprotective effects against SBI. Further studies are needed to confirm this. More importantly, the findings of the study stress the need to carefully reassess safety issues with high doses of melatonin, which is considered to be a practically non-toxic drug. © 2008 Springer-Verlag/Wien.
AB - Background Surgical brain injury (SBI) to normal brain tissue can occur as inevitable sequelae of neurosurgical operations. SBI can contribute to post-operative complications such as brain edema following blood-brain barrier (BBB) disruption leading to neurological deficits. Melatonin is a commonly used drug with known antioxidant properties and neuroprotective effects in experimental animal studies (Chen et al., J Pineal Res 41:175-182, 2006; Chen et al., J Pineal Res 40(3):242-250, 2006; Cheung, J Pineal Res 34:153-160, 2003; Lee et al., J Pineal Res 42(3):297-309, 2007; Reiter et al., Exp Biol Med (Maywood) 230(2):104-117, 2005) Methods We tested different concentrations of melatonin (5 mg/kg, 15 mg/kg and 150 mg/kg) administered 1 hour before surgery for neuroprotection against SBI using a rodent model. Post-operative assessment included brain water content (brain edema), lipid peroxidation assays (oxidative stress), and neurological assessment. Findings The results showed a trend in decreasing brain edema with lower doses of melatonin (5 mg/kg and 15 mg/ kg), however, high concentration of melatonin (150 mg/kg) significantly increased brain edema compared to all other groups. This deleterious effect of high-dose melatonin was also observed in lipid-peroxidation assay wherein lower-dose melatonin (15 mg/kg) attenuated oxidative stress, but high-dose melatonin (150 mg/kg) increased oxidative stress as compared to vehicle-treated group. Furthermore, high-dose melatonin also worsened neurological outcomes compared to other groups whereas; the low-dose melatonin group (15 mg/kg) showed some improved neurological parameters. Conclusions The study suggests that low-dose melatonin may provide neuroprotective effects against SBI. Further studies are needed to confirm this. More importantly, the findings of the study stress the need to carefully reassess safety issues with high doses of melatonin, which is considered to be a practically non-toxic drug. © 2008 Springer-Verlag/Wien.
KW - Brain-edema
KW - Melatonin
KW - Neuroprotection
KW - Surgical brain-injury
KW - Melatonin/therapeutic use
KW - Neuroprotective Agents/therapeutic use
KW - Rats
KW - Brain Injuries/complications
KW - Dose-Response Relationship, Drug
KW - Brain Edema/etiology
KW - Lipid Peroxidation/drug effects
KW - Animals
KW - Analysis of Variance
KW - Neurologic Examination/methods
KW - Disease Models, Animal
UR - https://link.springer.com/chapter/10.1007/978-3-211-85578-2_70
UR - https://www.mendeley.com/catalogue/6571c483-0686-3736-8f89-ea2641192830/
U2 - 10.1007/978-3-211-85578-2_70
DO - 10.1007/978-3-211-85578-2_70
M3 - Conference contribution
C2 - 19388347
SN - 9783211855775
SN - 978-3-211-99942-4
T3 - Acta Neurochirurgica, Supplementum
SP - 367
EP - 371
BT - Intracranial Pressure and Brain Monitoring XIII
PB - Springer Vienna
ER -